Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2002-06-19
2008-12-02
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S192100, C530S387300
Reexamination Certificate
active
07459158
ABSTRACT:
The invention relates to methods and materials involved in the treatment and prevention of various diseases such as infections and IgE-related diseases. Specifically, the invention relates to methods and materials that can be used to vaccinate a mammal against specific self or non-self antigens. For example, the methods and materials described herein can be used to reduce the effects of IgE antibodies within a mammal by reducing the amount of total and receptor bound IgE antibodies in the mammal. In addition, the invention provides vaccine conjugates, immunogenic polypeptides, nucleic acid molecules that encode immunogenic polypeptides, host cells containing the nucleic acid molecules that encode immunogenic polypeptides, and methods for making vaccine conjugates and immunogenic polypeptides as well as nucleic acid molecules that encode immunogenic polypeptides. Further, the invention provides an IgE vaccine that induces an anti-self IgE response in a mammal.
REFERENCES:
patent: 4483793 (1984-11-01), Vyas
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4703004 (1987-10-01), Hopp et al.
patent: 4767842 (1988-08-01), Stevens
patent: 4782137 (1988-11-01), Hopp et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5175385 (1992-12-01), Wagner et al.
patent: 5196197 (1993-03-01), Talwar et al.
patent: 5254671 (1993-10-01), Chang
patent: 5334379 (1994-08-01), Pillai et al.
patent: 5501855 (1996-03-01), Talwar et al.
patent: 5532142 (1996-07-01), Johnston et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5653980 (1997-08-01), Hellman
patent: 5698201 (1997-12-01), Stevens
patent: 5733553 (1998-03-01), Talwar et al.
patent: 5762931 (1998-06-01), Talwar et al.
patent: 5827668 (1998-10-01), Stanworth et al.
patent: 5837686 (1998-11-01), Kirby et al.
patent: 5874085 (1999-02-01), Mond et al.
patent: 5945104 (1999-08-01), Stanworth et al.
patent: 5955076 (1999-09-01), Stanworth et al.
patent: 6034066 (2000-03-01), Johnson et al.
patent: 2117193 (1993-04-01), None
patent: 2320960 (1999-02-01), None
patent: 0 327 378 (1989-08-01), None
patent: 0 396 505 (1990-11-01), None
patent: 0 403 312 (1990-12-01), None
patent: 0 752 886 (1998-01-01), None
patent: 0 841 946 (2002-10-01), None
patent: 1 009 382 (2003-06-01), None
patent: 0 821 003 (2003-08-01), None
patent: WO 89/04834 (1989-06-01), None
patent: WO 89/06138 (1989-07-01), None
patent: WO 91/01146 (1991-02-01), None
patent: WO 91/11456 (1991-08-01), None
patent: WO 94/05698 (1994-03-01), None
patent: WO 94/08601 (1994-04-01), None
patent: WO 95/05849 (1995-03-01), None
patent: WO 95/20606 (1995-08-01), None
patent: WO 95/26365 (1995-10-01), None
patent: WO9526356 (1995-10-01), None
patent: WO 96/12740 (1996-05-01), None
patent: WO 97/22699 (1997-06-01), None
patent: WO 97/31948 (1997-09-01), None
patent: WO 98/05684 (1998-02-01), None
patent: WO 98/46642 (1998-10-01), None
patent: WO 99/62550 (1999-12-01), None
patent: WO 99/67293 (1999-12-01), None
patent: WO 00/20027 (2000-04-01), None
patent: WO 00/32227 (2000-06-01), None
patent: WO 00/65058 (2000-11-01), None
patent: WO 02/09751 (2002-02-01), None
patent: WO 02/20038 (2002-03-01), None
patent: WO02/102320 (2002-12-01), None
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.
Nissim et al, EMBO J 10(1): 101-107, 1991.
Aveskogh et al, Eur J Immunol 28(9): 2738-50, Abstract.
Basu et al (J Biol Chemistry 268(18): 13118-13127, 1993.
Attwood et al, The Babel of Bioinformatics, 2000, Science vol. 290 No. 5491: 471-473.
Nechansky et al, Int Arch Allergy Immunol 120: 295-302, 1999.
Jaffery et al, Immunology 78(4): 635-42, Apr. 1993.
Demoly et al, Am J Respir Crit Care Med 156(5): 1707, Nov. 1997.
Paul et al (in Fundamental Immunology second edition, p. 826, Raven Press, New York, 1989.
Fahy et al, Am J Respir Crit Care Med 155(6): 1828-34, Jun. 1997.
Chemical Abstracts, vol. 129 (Columbus, Ohio), Griot-Wenk, M.E. et al., “Characterization of two dog IgE-specific antibodies elicited by different recombinant fragments of the epsilon chain in hens,” p. 1, Abstract No. 107756, Vet. Immunol. Immunopathol., 1998, 64(1):15-32.
Chemical Abstracts, vol. 128 (1999), (Columbus, Ohio, USA), Rudolf, Michael P. et al., “Epitope-specific antibody response to IgE by mimotope,” p. 1, Abstract No. 320498, J. Immunol., 1998, 160(7):3315-3321.
Dialog Information Services, file 155, MEDLINE, Dialog accession No. 07797491, Medline accession No. 93293823, Basu M. et al., “Purification and characterization of human recombinant IgE-Fc IgE receptor,” J. Biol. Chem., Jun. 25, 1993, 268(18):13118-13127.
Dialog Information Services, file 155, MEDLINE, Dialog accession No. 05892828, Medline accession No. 89212964, Glovsky MM et al., “Effect of monoclonal antihuman IgE on recombinant IgE (301-376) inhibition of specific IgE histamine release,” Int. Arch. Allergy Appl. Immunol., 1989, 88(1-2):203-205.
XVIth International congress of allergology and clinical immunology, Oct. 1997, Beda M. Stadler et al., “Anti-IgE Vaccination,” pp. 339-343, see p. 341, left column.
Baniyash et al.,Eur. J. Immunol., 1984, 14:799-807.
Baniyash et al.,Mol. Immun., 1988, 25(8):705-711.
Barouch et al.,J. Immunol., 1998, 161(4):1875-1882.
Basciano et al.,J. Biol. Chem., 1986, 261(25):11823-11831.
Burt et al.,Mol. Immunol., 1987, 24(4):379-389.
Burt et al.,Mol. Immun., 1986, 23(2):181-191.
Burt et al.,Eur. J. Immunol., 1987, 17:437-440.
Coleman et al.,Eur. J. Immunol., 1985, 15:966-969.
Cruse et al.,Illustrated Dictionary of Immunology, 1995, CRC Press Ind., pp. 83, 168-169.
Dalum et al.,J. Immunol., 1996, 157(11):4796-4804.
Dalum et al.,Mol. Immunol., 1997, 34(16-17):1113-1120.
Devlin (ed.),Textbook of Biochemistry, 2ndEdition, John Wiley & Sons, pp. 49-57.
Froese,CRC Crit. Rev. Immunol., 1980, 1:79-132.
Gordon,Int. Rev. Cytol., 1989, 115:171-229.
Geha,Annals of Allergy, Letter to the Editor, 1991, 66(5):359-360.
Geha et al.,Nature, 1985, 315:577-581.
Gossler et al.,Proc. Natl. Acad. Sci. USA, 1986, 83:9065-9069.
Gould et al.,Int. Archs. Allergy Appl. Immun., 1987, 82:392-393.
Gould,Clinical and Experimental Allergy, 1991, 21, Suppl. 1.
Haba et al.,J. Immunol. Methods, 1987, 105:193-199.
Haba et al.,Proc. Natl. Acad. Sci. USA, 1987, 84:5009-5013.
Haba et al.,Proc. Natl. Acad. Sci. USA, 1990, 87:3363-3367.
Hamburger,American Scientist, 1976, 64:157-164.
Hamburger,Annals of Allergy, Letter to the Editor, Jan. 1982, 68(1).
Hamburger,Science, 1975, 189:389-390.
Hamburger,Immunology, 1979, 38(4):781-787.
Hamburger,IgE and Allergy, pp. 95-112.
Hammer et al.,Nature, 1985, 315:680-683.
Hellman et al.,Nucleic Acids Res., 1982, 10:6041-6049.
Hellman,Eur. J. Immunol., 1994, 24:415-420.
Helm et al.,Nature, 1988, 331:180-183.
Helm et al.,Proc. Natl. Acad. Sci. USA, 1989, 86:9465-9469.
Helm et al.,J. Biol. Chem., 1996, 271:7494-7500.
Helm et al.,Allergy, 1997, 52:1155-1169.
Hogan et al.,Manipulating the Mouse Embryo, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1986.
Holgate,The Practitioner, 1989, 233:599-602.
Ishizaka,Advances in Immunology, 1989, 47:1-43.
Ishizaka et al.,Proc. Natl. Acad. Sci. USA, 1986, 83:8323-8327.
Johansson, “Anti-IgE Antibodies in Human Serum,”J. Allergy Clin. Immunol., 1986, 77(4):555-557.
Koike et al.,Monogr. Allergy, 1989, 26:165-175.
Kraemer et al.,Genetic Manipulation of the Early Mammalian Embryo, Cold Spring Harbor Press, Cold Spring Harbor, NY, 1985.
Krimpenfort et al.,Bio/Technology, 1991, 9:844-847.
Lederman et al.,Mol. Immunol., 1991, 28:1171-1181.
Li et al.,Proc. Natl. Acad. Sci. USA, 1980, 77:3211-3214.
Liou et al.,J. Immunol., 1989, 143:3967-3975.
Lowenadler et al.,Mol. Immunol., 1992, 29(10):1185-1190.
Maecker et al.,Vaccine, 1997, 15(5):1687-1696.
Margolskee et al.,Mol. C
Fish & Richardson P.C.
Huynh Phuong
Resistentia Pharmaceuticals AB
LandOfFree
Immunogenic polypeptides for inducing anti-self IgE responses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic polypeptides for inducing anti-self IgE responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic polypeptides for inducing anti-self IgE responses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4048064